Loading...
Rationale and clinical utility of the darunavir–cobicistat combination in the treatment of HIV/AIDS
This article is to provide an update overview of cobicistat (COBI)-boosted darunavir in response to its recent approval by the US Food and Drug Administration, and inclusion as an alternative first-line regime in the 2015 treatment guidelines in the US. COBI is a relatively new non-antiretroviral cy...
Na minha lista:
| Udgivet i: | Drug Des Devel Ther |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4627402/ https://ncbi.nlm.nih.gov/pubmed/26566368 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S63989 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|